MET and renal cell carcinoma: For those with known or likely pathogenic MET mutations causing HPRC, the risk of developing bilateral and/or multi-focal RCC is >80%, with some reporting penetrance rates of RCC to be >90%, which is amongst the highest rates of penetrance seen in hereditary RCC, with a median age of renal tumor diagnosis being 57 [77,78].